Cargando…

Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients

INTRODUCTION: Adult muscle fibers are a source of growth factors, including insulin-like growth factor-1 (IGF-1). These factors influence neuronal survival, axonal growth, and maintenance of synaptic connections. METHODS: We investigated the components of the IGF system in skeletal muscle samples ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Lunetta, Christian, Serafini, Massimo, Prelle, Alessandro, Magni, Paolo, Dozio, Elena, Ruscica, Massimiliano, Sassone, Jenny, Colciago, Clarissa, Moggio, Maurizio, Corbo, Massimo, Silani, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306791/
https://www.ncbi.nlm.nih.gov/pubmed/22246875
http://dx.doi.org/10.1002/mus.22288
_version_ 1782227243885395968
author Lunetta, Christian
Serafini, Massimo
Prelle, Alessandro
Magni, Paolo
Dozio, Elena
Ruscica, Massimiliano
Sassone, Jenny
Colciago, Clarissa
Moggio, Maurizio
Corbo, Massimo
Silani, Vincenzo
author_facet Lunetta, Christian
Serafini, Massimo
Prelle, Alessandro
Magni, Paolo
Dozio, Elena
Ruscica, Massimiliano
Sassone, Jenny
Colciago, Clarissa
Moggio, Maurizio
Corbo, Massimo
Silani, Vincenzo
author_sort Lunetta, Christian
collection PubMed
description INTRODUCTION: Adult muscle fibers are a source of growth factors, including insulin-like growth factor-1 (IGF-1). These factors influence neuronal survival, axonal growth, and maintenance of synaptic connections. METHODS: We investigated the components of the IGF system in skeletal muscle samples obtained from 17 sporadic amyotrophic lateral sclerosis patients (sALS) and 29 control subjects (17 with normal muscle and 12 with denervated muscle unrelated to ALS). RESULTS: The muscle expression of IGF-1 and IGF-binding proteins 3, 4, and 5 (IGF-BP3, -4, and -5, respectively), assessed by immunohistochemistry, was differently decreased in sALS compared with both control groups; conversely, IGF-1 receptor β subunit (IGF-1Rβ) was significantly increased. Western blot analysis confirmed the severe reduction of IGF-1, IGF-BP3, and -BP5 with the increment of IGF-1Rβ in sALS. CONCLUSION: In this study we describe the abnormal expression of the IGF-1 system in skeletal muscle of sALS patients that could participate in motor neuron degeneration and should be taken into account when developing treatments with IGF-1. Muscle Nerve, 2012
format Online
Article
Text
id pubmed-3306791
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Wiley Subscription Services, Inc., A Wiley Company
record_format MEDLINE/PubMed
spelling pubmed-33067912012-03-19 Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients Lunetta, Christian Serafini, Massimo Prelle, Alessandro Magni, Paolo Dozio, Elena Ruscica, Massimiliano Sassone, Jenny Colciago, Clarissa Moggio, Maurizio Corbo, Massimo Silani, Vincenzo Muscle Nerve Research Articles INTRODUCTION: Adult muscle fibers are a source of growth factors, including insulin-like growth factor-1 (IGF-1). These factors influence neuronal survival, axonal growth, and maintenance of synaptic connections. METHODS: We investigated the components of the IGF system in skeletal muscle samples obtained from 17 sporadic amyotrophic lateral sclerosis patients (sALS) and 29 control subjects (17 with normal muscle and 12 with denervated muscle unrelated to ALS). RESULTS: The muscle expression of IGF-1 and IGF-binding proteins 3, 4, and 5 (IGF-BP3, -4, and -5, respectively), assessed by immunohistochemistry, was differently decreased in sALS compared with both control groups; conversely, IGF-1 receptor β subunit (IGF-1Rβ) was significantly increased. Western blot analysis confirmed the severe reduction of IGF-1, IGF-BP3, and -BP5 with the increment of IGF-1Rβ in sALS. CONCLUSION: In this study we describe the abnormal expression of the IGF-1 system in skeletal muscle of sALS patients that could participate in motor neuron degeneration and should be taken into account when developing treatments with IGF-1. Muscle Nerve, 2012 Wiley Subscription Services, Inc., A Wiley Company 2012-02 /pmc/articles/PMC3306791/ /pubmed/22246875 http://dx.doi.org/10.1002/mus.22288 Text en Copyright © 2011 Wiley Periodicals, Inc. http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Research Articles
Lunetta, Christian
Serafini, Massimo
Prelle, Alessandro
Magni, Paolo
Dozio, Elena
Ruscica, Massimiliano
Sassone, Jenny
Colciago, Clarissa
Moggio, Maurizio
Corbo, Massimo
Silani, Vincenzo
Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients
title Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients
title_full Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients
title_fullStr Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients
title_full_unstemmed Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients
title_short Impaired Expression of Insulin-Like Growth Factor-1 System in Skeletal Muscle of Amyotrophic Lateral Sclerosis Patients
title_sort impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306791/
https://www.ncbi.nlm.nih.gov/pubmed/22246875
http://dx.doi.org/10.1002/mus.22288
work_keys_str_mv AT lunettachristian impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT serafinimassimo impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT prellealessandro impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT magnipaolo impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT dozioelena impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT ruscicamassimiliano impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT sassonejenny impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT colciagoclarissa impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT moggiomaurizio impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT corbomassimo impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients
AT silanivincenzo impairedexpressionofinsulinlikegrowthfactor1systeminskeletalmuscleofamyotrophiclateralsclerosispatients